OverviewSuggest Edit

Aspen Pharmacare is a global supplier of branded and generic pharmaceutical products. The company primarily sells therapeutic oils, rubs, and ointments. 

TypePublic
Founded1850
HQDurban, ZA
Websiteaspenpharma.com
Employee Ratings3.8

Latest Updates

Employees (est.) (Dec 2020)9,069(-8%)
Job Openings20
Revenue (FY, 2019)R38.9 B(-8%)
Share Price (Sept 2021)$13.7
Cybersecurity ratingBMore

Key People/Management at Aspen Pharmacare

Stephen Saad

Stephen Saad

Executive Director & Group Chief Executive
Gus Attridge

Gus Attridge

Executive Director; Deputy Group Chief Executive
Sean Capazorio

Sean Capazorio

Group Finance Officer
Kuseni Dlamini

Kuseni Dlamini

Independent Non-Executive, Chairman
Lorraine Hill

Lorraine Hill

Group Operating Officer and Responsible Pharmacist
Reginald Haman

Reginald Haman

Group Corporate Services Officer
Show more

Aspen Pharmacare Office Locations

Aspen Pharmacare has offices in Durban, Cape Town, East London, Port Elizabeth and in 54 other locations
Durban, ZA (HQ)
Rydall Vale Park, Douglas Saunders Dr & Armstrong Avenue, La Lucia Ridge
Cape Town, ZA
1st floor, 2 Century Blvd, Century City
Durban, ZA
Pencarrow Park, No. 2 Pencarrow Crescent, La Lucia Ridge
East London, ZA
5-7 Robbie De Lange Rd, Wilsonia
Port Elizabeth, ZA
7 Fairclough Rd, Holland Park
Sandton, ZA
Woodlands Dr, Gallo Manor
Show all (72)

Aspen Pharmacare Financials and Metrics

Aspen Pharmacare Revenue

Embed Graph
View revenue for all periods
Aspen Pharmacare's revenue was reported to be R38.87 b in FY, 2019 which is a 8.7% decrease from the previous period.
ZAR

Revenue (FY, 2019)

38.9b

Revenue growth (FY, 2018 - FY, 2019), %

(8.7%)

Gross profit (FY, 2019)

19.7b

Gross profit margin (FY, 2019), %

50.7%

Net income (FY, 2019)

2.0b

EBIT (FY, 2019)

4.6b

Market capitalization (2-Sept-2021)

6.5b

Closing stock price (2-Sept-2021)

13.7

Cash (30-Jun-2019)

9.0b

EV

45.5b
Aspen Pharmacare's current market capitalization is $6.5 b.
Annual
ZARFY, 2016FY, 2017FY, 2018FY, 2019

Revenue

35.6b41.2b42.6b38.9b

Revenue growth, %

16%3%(9%)

Cost of goods sold

17.7b21.3b21.0b19.2b

Gross profit

17.9b19.9b21.6b19.7b
Half Year
ZARH1, 2017H1, 2018H1, 2019

Revenue

19.8b21.9b19.7b

Cost of goods sold

10.3b10.7b9.4b

Gross profit

9.5b11.2b10.2b

Gross profit Margin, %

48%51%52%
Annual
ZARFY, 2016FY, 2017FY, 2018FY, 2019

Cash

10.9b10.7b11.2b9.0b

Accounts Receivable

9.0b10.9b11.0b

Inventories

14.4b13.6b14.5b14.6b

Current Assets

37.2b38.1b40.2b36.2b
Half Year
ZARH1, 2017H1, 2018H1, 2019

Cash

9.5b8.5b9.9b

Inventories

13.2b13.6b15.6b

Current Assets

36.3b36.1b45.3b

PP&E

9.7b10.1b11.7b
Annual
ZARFY, 2016FY, 2017FY, 2018FY, 2019

Net Income

9.0b8.3b9.2b5.1b

Depreciation and Amortization

1.2b1.3b1.4b1.3b

Inventories

(3.6b)(1.1b)(1.1b)(1.0b)

Accounts Payable

200.0m2.9b(274.0m)(1.2b)
Half Year
ZARH1, 2017H1, 2018H1, 2019

Cash From Operating Activities

3.2b3.0b1.7b

Capital Expenditures

(1.3b)(3.8b)(1.5b)

Cash From Investing Activities

(7.8b)(8.1b)(6.0b)

Dividends Paid

(1.1b)(1.3b)(1.4b)
ZARFY, 2016

Revenue/Employee

3.9m

Debt/Equity

1 x

Debt/Assets

0.4 x

Financial Leverage

2.5 x
Show all financial metrics

Aspen Pharmacare Operating Metrics

FY, 2016FY, 2017FY, 2018FY, 2019

Countries

150150150150

Manufacturing Facilities

262525

Manufacturing Sites

181717

Products Launched (Sub-Saharan Africa)

44301022
Show all operating metrics

Aspen Pharmacare Acquisitions / Subsidiaries

Company NameDateDeal Size
Alphamed INRJune 12, 2018r164 m
NorgineMay 21, 2015€29 m
Aspen Bad Oldesloe GmbH
Aspen Finance (Pty) Limited
Aspen France SAS
Aspen Germany GmbH
Aspen Global Inc.
Aspen Healthcare FZ LLC
Aspen Health LLC
Aspen Japan K.K.
Show more

Aspen Pharmacare Revenue Breakdown

Embed Graph

Aspen Pharmacare revenue breakdown by business segment: 14.9% from Manufacturing and 85.1% from Commercial Pharma

Aspen Pharmacare revenue breakdown by geographic segment: 5.5% from Japan, 7.4% from China, 6.5% from Developing Europe & CIS, 7.9% from Latin America, 11.4% from Australasia, 22.1% from Sub-Saharan Africa, 31.1% from Developed Europe and 8.2% from Other

Aspen Pharmacare Cybersecurity Score

Cybersecurity ratingPremium dataset

B

89/100

SecurityScorecard logo

Aspen Pharmacare Online and Social Media Presence

Embed Graph

Aspen Pharmacare News and Updates

Aspen Pharmacare to Deliver J&J Vaccines in Next Three Months

Aspen Pharmacare to Deliver J&J Vaccines in Next Three Months

Aspen Pharmacare Blogs

Aspen increases revenue from continuing operations by 12% to R37,8 billion

Johannesburg - JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, is pleased to report the following salient financial results for the year ended 30 June 2021: Revenue from continuing operations increased by 12% to R37,8 b…

Stephen Saad discusses the J&J vaccine release with eNCA’s Sally Burdett

Aspen confirmed on 26 July 2021 that the first supplies to South Africa of the Johnson & Johnson COVID-19 vaccines, from the new API source located in Europe, were being released to Johnson & Johnson from its flagship Gqeberha-based manufacturing site. These vaccines will be further …

ASPEN CONFIRMS RELEASE OF COVID-19 VACCINES TO JOHNSON & JOHNSON FOR SUPPLY TO SOUTH AFRICA

Durban, South Africa - Aspen, a global multinational specialty pharmaceutical company, is pleased to confirm that the first supplies to South Africa of the Johnson & Johnson COVID-19 vaccines, from the new API source located in Europe, will be released to Johnson & Johnson from its flags…

CNN Live – Aspen’s US$700m investment in equitable vaccine access for Africa

"Over 90% of our vaccines are imported. A high majority from #India. When India cut off all exports, #Africa was left without vaccines." Stephen Saad, CEO @aspenpharma discusses their recent $700M investment & ensuring future Africa supplies. https://player.vimeo.com/video/572460429 …

Aspen statement on manufacture and supply of COVID-19 vaccines

Durban – Aspen, a global multinational specialty pharmaceutical company, was extremely disappointed to learn over the past weekend that specific batches of the Johnson & Johnson COVID-19 vaccine manufactured at our Gqeberha production site and designated for the South African market have to be d…

French National Order of Merit conferred on Aspen’s Stephen Saad

Front left to right: President Ramaphosa, Savannah Saad, Stephen Saad, President Macron Stephen Saad being made Chevalier de l’Ordre national du Mérite by President Macron Pretoria – The Chevalier de l’Ordre national du Mérite (Knight of the French National …
Show more

Aspen Pharmacare Frequently Asked Questions

  • When was Aspen Pharmacare founded?

    Aspen Pharmacare was founded in 1850.

  • Who are Aspen Pharmacare key executives?

    Aspen Pharmacare's key executives are Stephen Saad, Gus Attridge and Sean Capazorio.

  • How many employees does Aspen Pharmacare have?

    Aspen Pharmacare has 9,069 employees.

  • What is Aspen Pharmacare revenue?

    Latest Aspen Pharmacare annual revenue is R38.9 b.

  • What is Aspen Pharmacare revenue per employee?

    Latest Aspen Pharmacare revenue per employee is R4.3 m.

  • Who are Aspen Pharmacare competitors?

    Competitors of Aspen Pharmacare include Octapharma, CVS Caremark Specialty Pharmacy and Cristalia.

  • Where is Aspen Pharmacare headquarters?

    Aspen Pharmacare headquarters is located at Rydall Vale Park, Douglas Saunders Dr & Armstrong Avenue, La Lucia Ridge, Durban.

  • Where are Aspen Pharmacare offices?

    Aspen Pharmacare has offices in Durban, Cape Town, East London, Port Elizabeth and in 54 other locations.

  • How many offices does Aspen Pharmacare have?

    Aspen Pharmacare has 72 offices.